Desire that feels like yours again.

PT-141 is bremelanotide, designed to increase sexual desire. The FDA-approved version is an injection for premenopausal women with acquired, generalized HSDD. Rebody’s troche and nasal spray are compounded, needle-free formats.

Rebody is preparing 10 mg/mL and 5 mg/mL nasal sprays in 5 mL bottles. The 5 mg/mL strength is not available in California. We’ll share pump output, sprays per dose, directions, price, and refill timing when orders open.

Use the number of sprays on your prescription label. It will list the pump output, sprays per dose, nostril directions, timing, and maximum frequency.

The phase 3 trials studied a 1.75 mg injection for 24 weeks. A separate crossover study tested one 20 mg intranasal dose in 18 premenopausal women. Rebody’s nasal spray comes in a 5 mL bottle with prescription-specific pump directions.

People with uncontrolled high blood pressure or known cardiovascular disease should not use the FDA-approved injection. Its label also covers temporary blood-pressure increases, heart-rate decreases, nausea, focal hyperpigmentation, pregnancy, and drug interactions.

No. Orders are closed. Join the list for the exact prescription directions, retail price, states served, refill timing, and dispensed package.